May 17

President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations. Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after … Read more

Stepping onto the scale is about as American as eating apple pie, watching baseball, and visiting the drive-thru at McDonald’s.  Since U.S. adult obesity rates have doubled since 1990 (from 21.2% in 1990 to 43.8% in 2022 for women, and 16.9% to 41.6% in 2022 for men), you’d think a weight-loss company like Weight Watchers … Read more

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health? Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda. Various studies have pointed toward GLP-1 RAs causing mental … Read more

Our country is obsessed with weight loss. From marathon gym sessions and trendy detox teas to the latest GLP-1 injections, people will try just about anything to get lean. But ask any legit health expert and they’ll tell you the truth: There’s no shortcut to losing weight. The only real way to drop pounds—and keep … Read more

FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss

Weight loss drugs have become an increasingly popular, but controversial, way of quickly shedding extra pounds over the past few years. Part of that controversy deals with the side effects caused by some of the more well-known medications like Ozempic and Mounjaro. According to the Obesity Medicine Association (OMA), researchers are continually analyzing the pros … Read more